Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Solarboom 2024: Fünf Gründe, die für diese Aktie sprechen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
757 Leser
Artikel bewerten:
(2)

EQS-News: Union Medical Healthcare and EuroEyes to form joint venture to develop ophthalmological services in Hong Kong and mainland China

EQS-News / 31/10/2019 / 08:29 UTC+8 
 
*[FOR IMMEDIATE RELEASE]* 
 
*/ 
Union Medical Healthcare and EuroEyes to form joint venture 
to develop ophthalmological services in Hong Kong and mainland China* 
 
(31 October 2019, Hong Kong) *Union Medical Healthcare Limited* ("Union 
Medical Healthcare", which together with its subsidiaries is referred to as 
the "UMH Group", SEHK stock code: 2138), a leading integrated medical group 
in Hong Kong, is pleased to announce that UMH Group entered into a 
non-binding memorandum of understanding ("MOU") with EuroEyes Group 
(EuroEyes International Eye Clinic Limited (SEHK stock code: 1846) and its 
subsidiaries are referred to as the "EuroEyes Group" ) on 30 October 2019 to 
establish a 50-50 joint venture in Hong Kong to develop ophthalmological 
services and related businesses in the city and mainland China. 
 
To develop the market of mainland China, the proposed joint venture, 
pursuant to the MOU, will begin with Guangzhou and Shenzhen where UMH Group 
and EuroEyes Group already have business presence. The registered 
ophthalmologists of EuroEyes Group will be the consultants in the proposed 
joint venture. All medical treatments at the clinics or service centres in 
Hong Kong under the proposed joint venture will be provided by 
ophthalmologists registered in Hong Kong. Personnel and employees who work 
for the proposed joint venture will have the opportunity to be trained in 
Germany. EuroEyes Group will be primarily responsible for medical matters 
while UMH Group will be primarily responsible for marketing and recruitment 
in Hong Kong. The two parties are negotiating the terms of the proposed 
joint venture and they expect to sign a definite agreement no later than 31 
December 2019. 
 
*Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of 
Union Medical Healthcare* said, "UMH Group is dedicated to developing and 
diversifying its medical services. Our cooperation with EuroEyes Group, 
which is a leading German ophthalmological clinic group, in providing 
ophthalmological services in mainland China and Hong Kong will enable UMH 
Group to tap the immense demand there. In mainland China, our proposed joint 
venture will commence operations first in Guangzhou and Shenzhen. This will 
fit in with UMH Group's strategy of expanding its business actively in the 
Guangdong-Hong King-Macao Greater Bay Area to tap the potential there. UMH 
has a professional medical team, a clinic network and an advantage in 
providing one-stop medical services in mainland China and Hong Kong. It will 
combine its strengths with EuroEyes Group's first-rate technology to 
consolidate its leading position in the market for high-end medical 
services." 
 
-End- 
 
*About Union Medical Healthcare Limited* 
Union Medical Healthcare as Hong Kong's largest non-hospital medical service 
provider, leveraging its core businesses of preventive and precision 
medicine, and committed to developing medical artificial intelligence by 
integrating its multi-discipline medical services. The move, which is 
supported by the Group's high-end branding and quality customer services, is 
aimed at offering customers safe and effective medical services with 
professionalism. 
 
The Group principally engages in the provision of one-stop medical and 
health care services in Greater China. The Group provides a full range of 
services and products under its well-known brands, including those of its 
one-stop aesthetic medical solutions provider DR REBORN which has ranked 
first in Hong Kong by sales for years, diagnostic and imaging centre HKAI, 
day procedure centre HKMED, specialty clinic SPECIALISTS CENTRAL, 
chiropractic services centre SPINE Central, health management centre 
re:HEALTH, vaccine Centre Hong Kong Professional Vaccine HKPV, Pediatric 
centre Primecare, oncology treatment centre reVIVE, comprehensive dental 
centre UMH DENTAL CARE and primary care clinics jointly established with 
Tencent Doctorwork. 
 
_*According to research conducted by Frost and Sullivan based on the revenue 
of medical service providers in 2018._ 
 
*For further information, please contact: 
iPR Ogilvy & Mather* 
Callis Lau / Molisa Lau / Francesca Yeung / Vivian Ng 
Tel: (852) 2136 6952 / 2136 6953 / 3920 7639 / 3920 7651 
Fax: (852) 3170 6606 
Email: umh@iprogilvy.com 
 
Document: http://n.eqs.com/c/fncls.ssp?u=UWKSQHOROK [1] 
Document title: Union Medical Healthcare and EuroEyes to form joint venture 
to develop ophthalmological services in Hong Kong and mainland China 
 
31/10/2019 Dissemination of a Financial Press Release, transmitted by EQS 
Group. 
The issuer is solely responsible for the content of this announcement. 
 
Media archive at www.todayir.com 
 
1: https://link.cockpit.eqs.com/cgi-bin/fncls.ssp?fn=redirect&url=9f473a01e1b56a350b2650e2234da856&application_id=901245&site_id=vwd&application_name=news 
 

(END) Dow Jones Newswires

October 30, 2019 20:29 ET (00:29 GMT)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2019 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.